Global Radiation Oncology
Market is expected to reach
USD 10.1 billion by 2025, according to a new report by Grand View Research,
Inc. Rising prevalence of cancer is the prime factor responsible for
substantial growth of radiation oncology market over the forecast period.
Technological advancements in radiotherapy resulted in
increased adoption of radiation oncology as primary treatment line of cancer.
Development of compact advanced radiotherapy options such as CyberKnife, Gamma
Knife, and tomotherapy complemented this growth. These advanced methods pose
lesser postoperative complications and faster recovery time.
Increasing per capita healthcare expenditure is also an
important macroeconomic factor driving the market growth. In addition, with the
aid of supportive government initiatives and awareness, patients are not
hesitant to opt for advanced treatment options. For instance, per capita health
expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014,
as stated by the World Bank Group.
Access Full research report on Global Radiation Oncology
Market: http://www.grandviewresearch.com/industry-analysis/radiation-oncology-market
Further key findings from the study suggest:
- External
Beam Radiation Therapy (EBRT) inclusive of compact advanced radiation
therapy, proton therapy, and Linear Accelerator (LINAC), held lucrative
share in the product segment of radiation oncology market in 2016.
- Brachytherapy
is likely to gain maximum share over the next eight years. Extensive usage
of brachytherapy for the treatment of prostate and breast cancer is
anticipated to govern the growth.
- EBRT
applications inclusive of prostate treatment, breast, lung, colorectal,
head, and neck cancer dominated application segment.
- Image
Guided Radiation Therapy (IGRT) contributed to technology with around
13.0% share in 2016. In this method, overall objective is to minimize the
exposure to the healthy surrounding tissue.
- 3-D
CRT technology is anticipated to grow at a lucrative growth rate over the
next 8 years. In this technique, radiation beams form the shape at the
specific site of cancer.
- North
America held maximum share in global radiation oncology market in 2016.
Developed health infrastructure, presence of many multinational players,
and greater per capita health infrastructure are the key factors
contributing to the dominance of this region over the forecast period.
- However,
uncertain health reforms post the U.S. presidential election of 2016
coupled with shortage in supply of radiopharmaceuticals is likely to
hinder the growth in this region.
- Varian
Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications
SA, C.R. Bard, Inc., IsoRay, Inc., Mevion Medical Systems, Nordion
(Canada) Inc., NTP, and Mallinckrodt Public Limited Company are some of
the key players operating in radiation oncology market.
View more reports of this category by Grand View Research
at: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research
has segmented the Global Radiation Oncology Market by product, application,
technology, and region:
Radiation Oncology Product Outlook (Revenue, USD Million;
2014 - 2025)
- External
Beam Radiation Therapy
·
Electron-Emitting High-Energy Linear
Accelerators (Linac)
·
Compact Advanced Radiotherapy Systems
§
Cyberknife
§
Gamma Knife
§
Tomotherapy
·
Proton Therapy
§
Cyclotron
§
Synchrotron
·
Brachytherapy
·
Seeds
·
Applicators and Afterloaders
·
Electronic Brachytherapy
·
Systemic Beam Radiation Therapy
·
Others
Radiation Oncology Application Outlook (Revenue, USD
Million; 2014 - 2025)
- External
Beam Radiation Therapy
- Prostate
Cancer
- Breast
Cancer
- Lung
Cancer
- Head
and Neck Cancer
- Colorectal
Cancer
- Others
- Internal
Beam Radiation Therapy
- Prostate
Cancer
- Gynecological
Cancer
- Breast
Cancer
- Cervical
Cancer
- Penile
Cancer
- Others
Radiation Oncology Technology Outlook (Revenue, USD
Million; 2014 - 2025)
- External
Beam Radiation Therapy
- Image-Guided
Radiotherapy (IGRT)
- Intensity
Modulated Radiotherapy (IMRT)
- Stereotactic
Technology
- Proton
Beam Therapy
- 3D
Conformal Radiotherapy (3D CRT)
- Volumetric
Modulated Arc Therapy (VMAT)
- Brachytherapy
- Low-Dose
Rate Brachytherapy
- High-Dose
Rate Brachytherapy
- Systemic
Beam Radiation Therapy
- Others
Radiation Oncology Regional Outlook (Revenue, USD
Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Mexico
- Brazil
- MEA
- South
Africa
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-radiation-oncology-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com